These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37475856)

  • 1. B cell abnormalities and autoantibody production in patients with partial RAG deficiency.
    Min Q; Csomos K; Li Y; Dong L; Hu Z; Meng X; Yu M; Walter JE; Wang JY
    Front Immunol; 2023; 14():1155380. PubMed ID: 37475856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.
    Delmonte OM; Villa A; Notarangelo LD
    Blood; 2020 Feb; 135(9):610-619. PubMed ID: 31942628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
    Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
    Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human RAG mutations: biochemistry and clinical implications.
    Notarangelo LD; Kim MS; Walter JE; Lee YN
    Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
    Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in understanding RAG deficiencies.
    Gennery A
    F1000Res; 2019; 8():. PubMed ID: 30800289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.
    Walter JE; Rosen LB; Csomos K; Rosenberg JM; Mathew D; Keszei M; Ujhazi B; Chen K; Lee YN; Tirosh I; Dobbs K; Al-Herz W; Cowan MJ; Puck J; Bleesing JJ; Grimley MS; Malech H; De Ravin SS; Gennery AR; Abraham RS; Joshi AY; Boyce TG; Butte MJ; Nadeau KC; Balboni I; Sullivan KE; Akhter J; Adeli M; El-Feky RA; El-Ghoneimy DH; Dbaibo G; Wakim R; Azzari C; Palma P; Cancrini C; Capuder K; Condino-Neto A; Costa-Carvalho BT; Oliveira JB; Roifman C; Buchbinder D; Kumanovics A; Franco JL; Niehues T; Schuetz C; Kuijpers T; Yee C; Chou J; Masaad MJ; Geha R; Uzel G; Gelman R; Holland SM; Recher M; Utz PJ; Browne SK; Notarangelo LD
    J Clin Invest; 2015 Nov; 125(11):4135-48. PubMed ID: 26457731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.
    Geier CB; Farmer JR; Foldvari Z; Ujhazi B; Steininger J; Sleasman JW; Parikh S; Dilley MA; Pai SY; Henderson L; Hazen M; Neven B; Moshous D; Sharapova SO; Mihailova S; Yankova P; Naumova E; Özen S; Byram K; Fernandez J; Wolf HM; Eibl MM; Notarangelo LD; Calabrese LH; Walter JE
    Front Immunol; 2020; 11():574738. PubMed ID: 33193364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAG Deficiency: Two Genes, Many Diseases.
    Delmonte OM; Schuetz C; Notarangelo LD
    J Clin Immunol; 2018 Aug; 38(6):646-655. PubMed ID: 30046960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutations and recombination activity in RAG-deficient patients.
    Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
    Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients.
    Cifaldi C; Rivalta B; Amodio D; Mattia A; Pacillo L; Di Cesare S; Chiriaco M; Ursu GM; Cotugno N; Giancotta C; Manno EC; Santilli V; Zangari P; Federica G; Palumbo G; Merli P; Palma P; Rossi P; Di Matteo G; Locatelli F; Finocchi A; Cancrini C
    J Clin Immunol; 2022 Jan; 42(1):130-145. PubMed ID: 34664192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.
    John T; Walter JE; Schuetz C; Chen K; Abraham RS; Bonfim C; Boyce TG; Joshi AY; Kang E; Carvalho BT; Mahajerin A; Nugent D; Puthenveetil G; Soni A; Su H; Cowan MJ; Notarangelo L; Buchbinder D
    J Clin Immunol; 2016 Oct; 36(7):725-32. PubMed ID: 27539235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.
    Bosticardo M; Pala F; Notarangelo LD
    Eur J Immunol; 2021 May; 51(5):1028-1038. PubMed ID: 33682138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HyperIgE in hypomorphic recombination-activating gene defects.
    Castiello MC; Brandas C; Capo V; Villa A
    Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGs and BUGS: An alliance for autoimmunity.
    Rigoni R; Grassi F; Villa A; Cassani B
    Gut Microbes; 2016 Nov; 7(6):503-511. PubMed ID: 27575988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.
    Matangkasombut P; Pichavant M; Saez DE; Giliani S; Mazzolari E; Finocchi A; Villa A; Sobacchi C; Cortes P; Umetsu DT; Notarangelo LD
    Blood; 2008 Jan; 111(1):271-4. PubMed ID: 17890453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
    Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
    Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency.
    Castiello MC; Bosticardo M; Sacchetti N; Calzoni E; Fontana E; Yamazaki Y; Draghici E; Corsino C; Bortolomai I; Sereni L; Yu HH; Uva P; Palchaudhuri R; Scadden DT; Villa A; Notarangelo LD
    J Allergy Clin Immunol; 2021 Jan; 147(1):309-320.e6. PubMed ID: 32387109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.
    Geier CB; Piller A; Linder A; Sauerwein KM; Eibl MM; Wolf HM
    PLoS One; 2015; 10(7):e0133220. PubMed ID: 26186701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.